Franklin Resources Inc. Has $108.74 Million Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Franklin Resources Inc. lowered its stake in IQVIA Holdings Inc. (NYSE:IQVGet Rating) by 1.7% in the second quarter, Holdings Channel.com reports. The institutional investor owned 501,138 shares of the medical research company’s stock after selling 8,579 shares during the quarter. Franklin Resources Inc.’s holdings in IQVIA were worth $108,742,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in IQV. Waldron Private Wealth LLC lifted its position in shares of IQVIA by 4.4% in the first quarter. Waldron Private Wealth LLC now owns 1,389 shares of the medical research company’s stock worth $321,000 after buying an additional 59 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in shares of IQVIA by 4.9% in the first quarter. Envestnet Asset Management Inc. now owns 521,370 shares of the medical research company’s stock worth $120,546,000 after purchasing an additional 24,308 shares during the period. Gladstone Institutional Advisory LLC increased its stake in shares of IQVIA by 13.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 1,543 shares of the medical research company’s stock worth $357,000 after purchasing an additional 179 shares during the period. Commonwealth Equity Services LLC increased its stake in shares of IQVIA by 2.2% in the first quarter. Commonwealth Equity Services LLC now owns 15,614 shares of the medical research company’s stock worth $3,610,000 after purchasing an additional 339 shares during the period. Finally, Victory Capital Management Inc. increased its stake in shares of IQVIA by 1.6% in the first quarter. Victory Capital Management Inc. now owns 151,589 shares of the medical research company’s stock worth $33,045,000 after purchasing an additional 2,439 shares during the period. Institutional investors and hedge funds own 86.77% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. StockNews.com assumed coverage on IQVIA in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. Barclays lifted their price objective on IQVIA from $215.00 to $235.00 and gave the stock an “overweight” rating in a research note on Thursday, October 27th. Morgan Stanley dropped their price objective on IQVIA from $260.00 to $240.00 and set an “overweight” rating on the stock in a research note on Thursday, October 27th. Robert W. Baird lifted their price objective on IQVIA to $266.00 in a research note on Thursday, October 27th. Finally, Mizuho lowered their price target on IQVIA from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Thursday, November 10th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $257.57.

IQVIA Stock Performance

Shares of IQVIA stock opened at $217.72 on Thursday. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.90 and a current ratio of 0.90. IQVIA Holdings Inc. has a 52 week low of $165.75 and a 52 week high of $285.61. The firm has a fifty day moving average of $196.79 and a two-hundred day moving average of $210.49. The stock has a market capitalization of $40.44 billion, a price-to-earnings ratio of 35.46, a PEG ratio of 2.06 and a beta of 1.37.

IQVIA Company Profile

(Get Rating)

IQVIA Holdings, Inc engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions and real-world solutions and services to the firm’s life science clients.

Featured Stories

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQVGet Rating).

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.